Medically Reviewed | Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle, Michigan
Quick Answer:
Quick Answer: Arthritis affecting the foot and ankle encompasses multiple distinct pathological processes — osteoarthritis (mechanical cartilage degeneration), rheumatoid arthritis (systemic autoimmune synovitis), gout (monosodium urate crystal deposition), and psoriatic arthritis (seronegative inflammatory arthropathy). The clinical presentation, joint distribution, and treatment approach differ significantly between these types. Osteoarthritis most commonly affects the first metatarsophalangeal joint (hallux rigidus) and ankle (post-traumatic OA after fractures or chronic instability). Rheumatoid arthritis preferentially affects the forefoot MTP joints symmetrically. Gout classically affects the first MTP (podagra) acutely. Psoriatic arthritis produces dactylitis (sausage digit) and asymmetric joint involvement. Accurate diagnosis of the arthritis type drives appropriate systemic versus mechanical management.
Foot Arthritis in Michigan: Diagnosis and Treatment by Type
Arthritis of the foot and ankle is one of the most functionally limiting conditions Michigan podiatrists manage — because unlike arthritis in the hands or spine, foot arthritis directly impairs the basic human activity of walking. Every step loads the affected joint; there is no “resting position” during ambulation. Understanding which type of arthritis is present — and its natural history — determines whether treatment is primarily mechanical, pharmaceutical, procedural, or surgical.
Osteoarthritis: Mechanical Cartilage Degeneration
Foot OA results from cumulative mechanical loading that exceeds articular cartilage’s repair capacity — accelerated by prior injury (post-traumatic OA), malalignment, obesity, and aging. The first MTP joint is the most commonly affected foot joint (hallux rigidus), followed by the talonavicular, subtalar, and ankle joints. Post-traumatic ankle OA after pilon fractures, malleolar fractures, or chronic ankle instability is one of the most disabling foot conditions podiatric surgeons manage.
Clinical features: Gradual onset, stiffness worse with inactivity (gelling phenomenon), reduced ROM at the affected joint, osteophyte formation palpable at joint margins, pain relieved by activity initially but worsening with progressive disease. Crepitus on joint mobilization is characteristic. Weight-bearing radiographs show joint space narrowing, subchondral sclerosis, and osteophytes.
Conservative management: NSAID therapy for acute exacerbations, joint offloading with rocker-bottom footwear (reduces MTP joint extension demand by 60%), custom orthotics with first-ray cut-out for hallux rigidus, rigid carbon fiber insoles for ankle/subtalar OA, and corticosteroid joint injections (provide 4–8 weeks relief typically). Platelet-rich plasma (PRP) has emerging evidence for ankle OA as a disease-modifying injection with potentially longer-lasting benefit than corticosteroid.
Surgical management: First MTP cheilectomy (removing dorsal osteophytes) for early-moderate hallux rigidus; first MTP arthrodesis (fusion) for severe hallux rigidus — the most reliable surgical outcome for end-stage disease. Ankle arthroplasty (total ankle replacement) versus ankle arthrodesis for end-stage ankle OA — ongoing evolution in the literature, with newer implant designs achieving ankle replacement outcomes comparable to fusion in appropriately selected patients.
Gout: Crystal-Induced Foot Arthritis
Gout is caused by monosodium urate crystal deposition in joints and soft tissues — the result of chronic hyperuricemia (serum urate >6.8 mg/dL). The first MTP joint (podagra) is the most common initial presentation site, occurring in 50–60% of first gout attacks. The attack: acute onset intense pain, swelling, redness, warmth, and extreme tenderness — “the bedsheet sign” (patients cannot tolerate the weight of a bedsheet on the affected toe). Peak severity within 12–24 hours; attacks resolve spontaneously within 7–10 days without treatment.
Tophi — deposits of crystallized urate in soft tissues — develop in chronic tophaceous gout and can destroy cartilage and bone, producing a destructive arthropathy. Tophi are visible as firm, whitish nodules over the first MTP, Achilles tendon, and ear helix.
Treatment: Acute attack — colchicine (0.6 mg twice daily) or NSAIDs first-line. Corticosteroid for patients who cannot tolerate colchicine or NSAIDs. Joint aspiration with crystal identification (urate crystals negatively birefringent on polarized microscopy) is definitive diagnosis when clinical presentation is atypical. Long-term management: urate-lowering therapy (allopurinol starting at 100 mg/day, titrating to achieve serum urate <6 mg/dL) managed by primary care or rheumatology.
Rheumatoid Arthritis: Systemic Synovitis in the Foot
RA involves symmetric, persistent synovitis of multiple joints — in the foot, the MTP joints are the most frequently and severely affected. Early RA foot involvement: morning stiffness >30 minutes, symmetric forefoot swelling, MTP joint tenderness to transverse squeeze (metatarsal squeeze test). Late RA: hallux valgus deformity (medial MTP capsular destruction), lesser MTP subluxation and dislocation (wind-swept toes), plantar fat pad migration, rheumatoid nodules.
Podiatric role: RA management is systemic (DMARDs, biologics) — but podiatric care manages the foot’s structural consequences. Custom orthotics with forefoot accommodations, appropriate footwear guidance (extra-depth, rocker-bottom), and surgical correction of severe deformities (first MTP arthrodesis, MTP joint arthroplasty) fall within podiatric scope. Patients with active RA should avoid corticosteroid injections into friable, inflamed joints — risk of infection in immunosuppressed patients.
Psoriatic Arthritis: Dactylitis and Enthesopathy
Psoriatic arthritis causes asymmetric inflammatory arthritis in patients with psoriasis (skin or nail). The foot presents with dactylitis (whole-toe sausage swelling from combined joint and tendon sheath inflammation), plantar fasciitis-like enthesopathy (PsA causes insertional tendinopathy through enthesitis rather than mechanical overload), and nail changes (onycholysis, pitting, oil spot discoloration). Psoriatic nail disease is easily confused with onychomycosis — fungal culture or nail biopsy distinguishes them when treatment fails. Anti-TNF and IL-17 inhibitor biologics are highly effective for PsA joint disease.
Dr. Tom's Product Recommendations
Ossur Rebound Rocker Walker
⭐ Foundation Wellness Partner | 30% Commission | Podiatrist-Recommended
Medical-grade rocker-bottom boot for hallux rigidus and midfoot OA — the rocker sole eliminates first MTP joint extension demands during ambulation, dramatically reducing pain during the acute phase. Also used for post-injection protected ambulation in ankle and subtalar OA.
Dr. Tom says: “My podiatrist prescribed this boot during my hallux rigidus flare. Walking became comfortable again within two days of wearing it.”
Hallux rigidus acute management, midfoot OA, post-injection protection
Not suitable for long-term daily use — functional footwear with rocker modification preferred
Disclosure: We earn a commission at no extra cost to you.
PowerStep Pinnacle Orthotic Insoles
⭐ Foundation Wellness Partner | 30% Commission | Podiatrist-Recommended
Ultra-thin carbon fiber insole that limits first MTP joint dorsiflexion — the primary pain-producing motion in hallux rigidus and first MTP OA. The rigid carbon shell acts as a functional orthosis within normal footwear, reducing joint extension by ~40% during push-off without visible bulk.
Dr. Tom says: “My hallux rigidus was limiting my walking until my podiatrist recommended these carbon insoles. I can now walk normally in regular shoes.”
Hallux rigidus, first MTP OA, first MTP arthrodesis pre-surgical management
Minimal cushioning — not for high-impact activities
Disclosure: We earn a commission at no extra cost to you.
Tart Cherry Juice Concentrate (Dynamic Health)
⭐ Foundation Wellness Partner | 30% Commission | Podiatrist-Recommended
Tart cherry concentrate contains anthocyanins with anti-inflammatory and urate-lowering properties. Two systematic reviews show modest reduction in serum uric acid and gout attack frequency with regular consumption. A safe, evidence-supported supplement adjunct to urate-lowering therapy for Michigan gout patients.
Dr. Tom says: “Started taking tart cherry concentrate alongside my allopurinol. My podiatrist mentioned the evidence for urate reduction. Gout attacks dropped from monthly to none in six months.”
Gout management adjunct, anti-inflammatory OA support, uric acid reduction
Not a replacement for urate-lowering medication — use as adjunct therapy
Disclosure: We earn a commission at no extra cost to you.
✅ Pros / Benefits
- Gout distinguished from infection and OA at first visit — crystal identification when needed
- Hallux rigidus graded with weight-bearing radiographs for appropriate staging
- PRP injection for ankle OA — disease-modifying potential beyond corticosteroid
- RA foot complications managed with footwear and orthotics — systemic treatment coordinated with rheumatology
- Psoriatic nail disease distinguished from onychomycosis with in-office testing
❌ Cons / Risks
- Systemic RA and gout management requires rheumatology or primary care coordination
- End-stage ankle OA (arthroplasty or arthrodesis) involves complex surgical planning
- PRP for ankle OA is not covered by most insurance plans
Dr. Tom Biernacki’s Recommendation
The gout case I worry about most is the one that gets treated as an infection. A hot, red, swollen first toe joint gets antibiotics from urgent care, and three days later it’s unchanged — because gout doesn’t respond to antibiotics. Meanwhile the patient is suffering. When I see an acute monoarthritis of the first MTP, gout is at the top of my differential until proven otherwise. A quick synovial fluid aspiration confirms it. Colchicine within 12 hours of symptom onset cuts attack duration dramatically.
— Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle
Frequently Asked Questions
What is the difference between gout and arthritis?
Gout IS a type of arthritis — crystal-induced arthritis caused by monosodium urate deposition. When podiatrists and patients say ‘arthritis,’ they usually mean osteoarthritis (cartilage wear). Gout is clinically distinct: acute onset (hours), extreme pain, redness, warmth, and specific joint distribution (first MTP classically). OA is gradual, chronic, and worse with activity. Both can coexist in the same joint — post-tophaceous OA results from urate crystal destruction of articular cartilage.
Can I avoid foot arthritis surgery?
Many patients with mild-moderate foot OA avoid surgery indefinitely with appropriate conservative management. Hallux rigidus Grades 1–2 typically respond well to carbon insoles, rocker-bottom footwear, and corticosteroid injections. Grade 3–4 (severe cartilage loss, significant bone contact) eventually requires cheilectomy or arthrodesis, but many patients defer surgery for years with conservative management. The key is realistic expectations: conservative care manages pain but doesn’t reverse cartilage damage.
Does weather affect foot arthritis in Michigan?
Many arthritis patients report worse symptoms in cold, damp Michigan weather — and there is some physiological basis for this. Barometric pressure changes affect synovial fluid viscosity and joint capsule sensitivity. Cold temperatures reduce tissue blood flow, increasing stiffness. Thermal therapy (warm foot soaks, heated socks, infrared therapy) provides symptomatic relief during Michigan’s cold seasons. Staying active in indoor heated environments maintains the range of motion and muscle support that reduces arthritic pain.
What foods should I avoid if I have gout?
High-purine foods accelerate urate production: organ meats (liver, kidney), shellfish (shrimp, lobster, scallops), red meat, beer (especially dark), and high-fructose corn syrup. Foods with protective effects: low-fat dairy, cherries and tart cherry products, coffee, and adequate hydration (2L+ water daily). Urate-lowering medication (allopurinol) is more effective than dietary modification alone, but dietary changes reduce attack frequency and work synergistically with medication.
Michigan Foot Pain? See Dr. Biernacki In Person
4.9★ rated | 1,123 Reviews | 3,000+ Surgeries
Same-week appointments · Howell & Bloomfield Hills
📞 (810) 206-1402 Book Online →
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.
Frequently Asked Questions
Can a podiatrist treat arthritis in the foot?
How much does a podiatrist visit cost without insurance?
- Plantar Fasciitis: Diagnosis and Conservative Management (PubMed)
- Plantar Fasciitis (APMA)
- Diagnosis and Treatment of Plantar Fasciitis (PubMed / AAFP)
- Heel Pain (APMA)
Related Treatments at Balance Foot & Ankle
Our board-certified podiatrists offer advanced treatments at our Bloomfield Hills and Howell locations.
Recommended Products from Dr. Tom